You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

May 3, 2019

Vietnam: Recent Verdicts Reveal Gaps in Derivative Work Protection

Managing Intellectual Property

During the early months of 2019, the Vietnam IP field enjoyed a rare burst of public attention. First there was the wide reaction to the IP changes ushered in by CPTPP, which took effect on 14 January 2019. Then the spotlight moved to two high-profile copyright lawsuits related to derivative works, when the People’s Court of Ho Chi Minh City’s District 1 returned a verdict in a 12-year-old case on 18 February 2019, and the People’s Court of Hanoi issued its decision on a similar case on 20 March 2019. The cases were heard by courts at opposite ends of the country, and the results might also be called “opposite.”

The Disputes

The HCMC case involved an artist named Le Phong Linh who worked for a company named Phan Thi. In 2001, at the request of the company, Mr. Linh created the comic book series Than Dong Dat Viet (Prodigy of Vietnam). In 2002, the images of the four main characters of the series were registered for copyright, recording Phan Thi as the owner of the work, and the company’s director and the artist as co-creators. Mr. Linh continued working on subsequent issues of the comic until the 78th issue, after which he quit. The dispute arose in 2007 when the artist discovered that, after he left, Phan Thi continued to publish new issues of the comic, while also creating variants of the original characters he created.

The Hanoi case involved an entertainment company that commissioned a famous director to develop a script and staging for a folk-inspired outdoor performance spectacle. The performance script was registered for copyright. However, the company eventually terminated the contract and commissioned another director to develop a new performance called Tinh Hoa Bac Bo (Quintessence of Tonkin), which became a big success. The dispute arose when the famous director claimed that Tinh Hoa Bac Bo was a derivative work from his first script, and asked the court to recognize this fact.

Different Courts, Different Judgments

In the Than Dong Dat Viet case, the court ruled that the images of the four characters were a work of applied art, a type of copyrighted work for which the artist was the sole creator; therefore, the company director was not acknowledged as a co-creator, even though she supported and provided ideas for Mr. Linh. The court also identified the variants of the four characters as derivative works. More importantly, the court argued that the creation of derivative works without the artist’s permission (as only the artist held moral rights) was a violation of his right “to protect the integrity of the work, to not allow others to modify, mutilate or distort the work in any way that is detrimental to the author’s honor and reputation” (Article 19.4 of the IP Law). The consequence of this finding was that the court ruled that the publisher’s release of subsequent issues of the comic series after the artist’s departure was illegal.

Meanwhile, in Hanoi, the court ruled that the later play was a derivative work, but it did not recognize the right to authorize the creation of the derivative work as a moral right, viewing it instead under the scope of economic rights. Therefore, the court judged that the entertainment company which commissioned the work was the owner of the original work (by controlling the economic rights), and naturally had the right to control the creation of derivative works made from it. The author still owned the moral rights, but the creation of derivative works, in the Hanoi court’s view, did not violate his moral rights. This finding was completely contrary to the court’s judgment in the Than Dong Dat Viet case.

Challenges to Overcome

The difference in verdicts despite the similar nature of the cases probably stems from internal conflicts in Vietnamese copyright law, which falls somewhere between the authors’ rights system found in places like France, and the copyright system typified by American law. This led to the courts’ defensible yet ultimately illogical view that the right to permit the creation of derivative works fell under economic rights (Article 20.1a of the IP Law), which belong to the copyright owner, but was also related to the moral right “to protect the integrity of the work,” which belongs to the creator –a paradox if the copyright owner and the creator of the work are different people.

In addition, Article 4.8 of Vietnam’s IP Law provides a closed list of types of protectable derivative works, including works which are “translated, adapted, modified, transformed, compiled, annotated, or selected from (original) works.” No clearer definition is given in the guiding legislation. This weakness was revealed in both judgments when the courts acknowledged that the works, while seemingly derivative, did not obviously fall into any of the “closed” legal categories under the law.

Such matters of principle need to be quickly addressed by the courts at the higher levels to help stabilize the legal system so all parties feel safer in their operations.

RELATED INSIGHTS​ 

June 24, 2026
Patent enablement requirements are provided under Article 102 of Vietnam’s Law on Intellectual Property (IP Law). In particular, a patent specification must “fully and clearly disclose the nature of the invention to such an extent that, based on the specification, a person having ordinary skill in the relevant art can implement the invention.” In pharmaceutical and biotechnology patents, this requirement is more complicated and subject to more rigorous assessment. The Patent Examination Guidelines (Guidelines) of the Intellectual Property Office of Vietnam (IP Office) were amended in March 2026 to introduce Annexes III and IV for the pharmaceutical and biotechnology sectors, in which Annex III provides detailed guidelines on the assessment of specification requirements. These amendments were made under a project for strengthening capacity in industrial property examination between the Japan International Cooperation Agency (JICA) and the IP Office. Annex III provides detailed instructions on how examiners assess enablement in a pharmaceutical or biotechnology application, and offers examples of acceptable and unacceptable descriptions with regard to the enablement aspect. Enablement Requirements in Pharma and Biotech Patents Article 12.7 of Circular 10/2026/TT-BKHCN (Circular 10) adds to the requirements of Article 102 of the IP Law that the description must demonstrate the novelty, inventive step, and industrial applicability of the technical solution. For pharmaceutical composition subject matters, Article 12.9 of Circular 10 sets out that the description must present the results of clinical trials and/or the pharmacological effects of the claimed pharmaceutical composition, and must include at least the following information: Substance/mixture used. Testing method (system) employed. Information on the test results. Correlation between the pharmacological effects obtained from the tests and the application of the pharmaceutical product in the prevention, diagnosis, and treatment of diseases. The Guidelines note that pharmacological study results should be presented in a quantified manner, and pharmacological
June 16, 2026
Since the implementation of the Trademark Law 2019 on April 1, 2023, Myanmar has operated under a modern first-to-file trademark system that brings its registration framework closer to international practice. As the new regime continues to develop in practice, applicants are increasingly required to navigate formal examination requirements, substantive objections, and procedural deadlines with greater precision. This article provides a high-level review of the trademark examination process in Myanmar, focusing on the principal stages from initial review to approval, the types of objections commonly raised by the Intellectual Property Department (IPD), and the key considerations for responding effectively. A clear understanding of these issues is essential for applicants seeking to secure registration efficiently and to mitigate avoidable delays or refusals. Examination Process: Key Stages Trademark applications filed with the IPD undergo two stages of review. Formality Examination The IPD first verifies compliance with procedural requirements, including: Correct Nice Classification Clear mark representation Accurate applicant details Clearly defined goods or services Representative details, if the application is filed by a representative Other formality requirements cover translation and transliteration of any non-English or non-Myanmar elements in the mark, color claim details, applicable disclaimers, and payment of official fees. Deficiencies result in an office action requiring correction within 30 days, which may be extended upon request. Registrability Examination The IPD also assesses registrability. A mark may be refused if it: Lacks distinctiveness Is descriptive or generic Misleads the public or violates public order/morality Contains prohibited state symbols Only compliant applications proceed to publication. Responding to Office Actions Applicants must respond within 30 days of notification from the IPD. Depending on the nature of the objection, strategies may include submitting legal arguments for distinctiveness, providing evidence of acquired distinctiveness, filing appropriate disclaimers, clarifying descriptions such as color claims, or amending the listed goods
June 15, 2026
The surge in AI development has led to a desperate demand for large, high-quality training data. However, real-world data can be expensive to collect, difficult to access, and often subject to strict privacy and regulatory constraints. Synthetic data, which consists of artificially generated records that replicate the statistical properties of real-world data without reproducing specific individuals’ information, provides an appealing solution by generating artificial datasets at scale without relying on identifiable personal information. It combines speed, cost efficiency, and regulatory compliance, making it a sensible alternative for organizations seeking to reduce risks while maintaining data utility. When properly anonymized, synthetic datasets may fall outside the scope of laws such as the EU’s General Data Protection Regulation (GDPR) or Thailand’s Personal Data Protection Act (PDPA), reducing compliance burdens while still supporting high-quality model training. However, relying on synthetic data without rigorous legal due diligence could be a strategic mistake. It replaces one set of known risks (scraping, direct privacy liability) with a new set of complex liabilities. The narrative that synthetic data is a “silver bullet” for privacy and IP compliance is dangerous and could be misleading. While synthetic data addresses data scarcity, it also introduces new legal uncertainties. Legal counsel should anticipate downstream risks arising from compromised data sources. Models trained on unlawfully obtained data may need to be decommissioned, even if their outputs appear lawful. What is synthetic data? Synthetic data refers to artificially generated information created using AI techniques such as deep learning and generative models. Instead of copying real records, it reproduces the statistical patterns and relationships found in the original dataset. Synthetic data generally falls into three categories: Fully synthetic data – Entirely new data points generated from learned patterns. The model studies the structure of the original data and produces records that resemble real-world
June 10, 2026
In March 2026, the Intellectual Property Office of Vietnam (IP Office) issued a decision refusing a trademark application after considering an opposition based primarily on copyright grounds. The outcome is noteworthy because the foreign brand owner had neither trademark registrations nor applications in Vietnam at the time the opposition was filed, and the IP Office has historically applied a stringent approach to oppositions relying on copyright. The Opposition Maurten is a well-known Swedish sports nutrition brand recognized globally for its innovative hydrogel technology, which is designed to help endurance athletes fuel more effectively without gastrointestinal discomfort. The brand’s distinctive logo is characterized by clean lines and a bold black-and-white color scheme, and has long been associated with the company’s performance products. The brand’s logo is displayed above. An identical mark was filed for registration by a Vietnamese trademark squatter. In 2023, a Vietnamese individual filed an application for registration of an identical mark (Application No. 4-2023-38668), a practice commonly observed in Vietnam as trademark squatting. The brand owner engaged Tilleke & Gibbins to assist with strategy and filing an opposition to the mark. At the time, Maurten had no trademark rights or meaningful use in Vietnam, and global marketing data showed only modest figures without any local presence. Thus, to convince the IP Office to refuse the squatter’s application, instead of relying on trademark rights or use evidence, the opposition strategy centered on the copyright protection of the logo itself, as copyright arises automatically in Vietnam upon creation of the work and does not require registration. (It is worth noting, however, that the IP Office has traditionally been cautious in accepting copyright as a basis for refusing trademark applications.) On September 24, 2024, an opposition was filed on three main grounds: confusing similarity, copyright infringement of the artistic work,